| CKPT Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CKPT market cap history going back to 8/4/2017:
Also see: CKPT Shares Outstanding History and CKPT YTD Return |
CKPT Market Cap History — Checkpoint Therapeutics Capitalization Over Time
As of 3/25/2025 Checkpoint Therapeutics has a market cap of 337.24 million. Investors often follow the CKPT market cap history to compare the size of the company over time.
This page shows CKPT market capitalization trends over time, with 27 market cap datapoints presented, dating back to 8/4/2017.
| CKPT Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CKPT Historical Market Cap: +9.78% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CKPT Stock Price Chart |
| About Checkpoint Therapeutics Inc |
| Checkpoint Therapeutics, Inc. is a clinical-stage immunotherapy and targeted oncology company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers. Co. is evaluating its lead antibody product candidate, cosibelimab, a potential best-in-class anti-programmed death-ligand 1 (PD-L1) antibody licensed from the Dana-Farber Cancer Institute, as a potential new treatment for patients with selected recurrent or metastatic cancers, including metastatic and locally advanced cutaneous squamous cell carcinoma. We show 27 historical shares outstanding datapoints in our CKPT shares outstanding history coverage, used to compute CKPT market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CKPT market cap history over the course of time is important for investors interested in comparing CKPT's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CKPT versus a peer is one thing; comparing CKPT market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CKPT can fluctuate over the course of history. With this page we aim to empower investors researching CKPT by allowing them to research the CKPT market cap history. |
| CKPT Current Stock Quote |
Quotes delayed 20 minutes  Free CKPT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| CKPT Share Performance |
| Market Cap Peers |
| Checkpoint Therapeutics (CKPT) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CLBS Market Cap History CLDX Market Cap History CLNN Market Cap History CLOV Market Cap History CLPT Market Cap History CLRB Market Cap History CLSD Market Cap History CLSN Market Cap History CLVS Market Cap History CLXT Market Cap History More Healthcare companies » |
CKPT Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
